Keyphrases
Bile Acids
61%
CYP2C70
57%
Human-like
47%
Bile Acid Composition
46%
Liver Pathology
30%
Hydroxylated
30%
Hydrophobicity
20%
Gene-deficient Mice
15%
Acid Activation
15%
Weight Loss
15%
Hepatic Steatosis
15%
Bile Acid Pool
14%
Obeticholic Acid
14%
Low Production
14%
Fat Absorption
14%
Microbiota Depletion
14%
Colesevelam
14%
Cholangiopathy
14%
Gut Microbiota
14%
KO Mice
14%
Acid Treatment
14%
Sequestration
14%
Insulin Resistance
14%
Type 2 Diabetes Mellitus (T2DM)
14%
People with Obesity
14%
Western Diet
7%
Muricholic Acid
7%
WT Mice
6%
Insulin Sensitivity
5%
Chenodeoxycholic Acid
5%
Antibiotics
5%
Medicine and Dentistry
Bile Acid
100%
Ursodeoxycholic Acid
33%
Bile Duct Disease
30%
Liver Pathology
30%
Fibrosis
18%
Neonatal Cholestasis
16%
Lipid Absorption
16%
Fatty Liver
15%
Gut Microbiota
14%
Colesevelam
14%
Obeticholic Acid
14%
Perinatal Exposure
14%
Insulin Resistance
14%
Maturity Onset Diabetes of the Young
11%
Chenodeoxycholic Acid
8%
Antibiotics
7%
Transaminase
7%
Liver Function
6%
Bile Acid Metabolism
5%
Disease Course
5%
Insulin Sensitivity
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Acid
64%
Mouse
57%
Hydrophobicity
18%
Fatty Liver
16%
Ursodeoxycholic Acid
15%
Intestine Flora
14%
Knockout Mouse
14%
Colesevelam
14%
Bile Duct Disease
14%
Fibrosis
14%
Insulin Resistance
14%
Non Insulin Dependent Diabetes Mellitus
10%
Antibiotic Agent
8%
Wild Type Mouse
6%
Microbiome
5%
Chenodeoxycholic Acid
5%